Synthesis of aza mono, bi and tricyclic compounds.: Evaluation of their anti MDR activity

被引:44
作者
Gallo, S
Atifi, S
Mahamoud, A
Santelli-Rouvier, C
Wolfárt, K
Molnar, J
Barbe, J
机构
[1] Univ Mediterranee, CNRS, UMR 6009, GERCTOP,Fac Pharm, F-13385 Marseille 5, France
[2] Univ Szeged, Inst Microbiol, Szeged, Hungary
关键词
P-gp inhibitors; acridinic compounds; pyridoquinolines;
D O I
10.1016/S0223-5234(02)01422-8
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Anti MDR activity of a series of acridine, pyridoquinoline, quinoline and pyridine analogous amines was evaluated. Interesting activity is displayed by tricyclic compounds. Besides ring size, influence of the side chain was studied. (C) 2002 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
引用
收藏
页码:19 / 26
页数:8
相关论文
共 21 条
  • [1] Hydrogen-bond basicity pKHB scale of six-membered aromatic N-heterocycles
    Berthelot, M
    Laurence, C
    Safar, M
    Besseau, F
    [J]. JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2, 1998, (02): : 283 - 290
  • [2] Inhibition of Trypanosoma cruzi trypanothione reductase by acridines:: Kinetic studies and structure-activity relationships
    Bonse, S
    Santelli-Rouvier, C
    Barbe, J
    Krauth-Siegel, RL
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (26) : 5448 - 5454
  • [3] SYNTHESIS OF ANTIMALARIALS .4. THE SYNTHESIS OF CERTAIN COMPOUNDS RELATED TO QUINACRINE
    BRESLOW, DS
    WALKER, HG
    YOST, RS
    SHIVERS, JC
    HAUSER, CR
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1946, 68 (01) : 100 - 102
  • [4] Chiba P, 1996, MOL PHARMACOL, V49, P1122
  • [5] Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein
    Dey, S
    Ramachandra, M
    Pastan, I
    Gottesman, MM
    Ambudkar, SV
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) : 10594 - 10599
  • [6] Ecker G, 1999, MOL PHARMACOL, V56, P791
  • [7] BIOCHEMISTRY OF MULTIDRUG-RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
    GOTTESMAN, MM
    PASTAN, I
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1993, 62 : 385 - 427
  • [8] Hevér A, 1998, ANTICANCER RES, V18, P3053
  • [9] Quantitative structure-activity relationship of multidrug resistance reversal agents
    Klopman, G
    Shi, LM
    Ramu, A
    [J]. MOLECULAR PHARMACOLOGY, 1997, 52 (02) : 323 - 334
  • [10] Observations on the strength of hydrogen bonding
    Laurence, C
    Berthelot, M
    [J]. PERSPECTIVES IN DRUG DISCOVERY AND DESIGN, 2000, 18 : 39 - 60